Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -32.29 Million NZD | 1.53% |
| 2023 | -32.79 Million NZD | -36.5% |
| 2022 | -23.45 Million NZD | -31.86% |
| 2021 | -16.54 Million NZD | -0.6% |
| 2020 | -19.27 Million NZD | 42.51% |
| 2019 | -19.02 Million USD | 9.22% |
| 2018 | -20.94 Million USD | 11.81% |
| 2017 | -21.91 Million USD | -94.82% |
| 2016 | -17.38 Million USD | -24.82% |
| 2015 | -12.5 Million NZD | -19.41% |
| 2014 | -9.56 Million NZD | -66.17% |
| 2013 | -6.71 Million NZD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -5.31 Million USD | 46.08% |
| 2024 Q2 | -5.19 Million USD | -71.88% |
| 2024 FY | - NZD | -64.76% |
| 2024 Q4 | -4.63 Million USD | 0.0% |
| 2024 Q3 | -4.89 Million USD | 47.97% |
| 2023 FY | - NZD | -36.5% |
| 2023 Q4 | -5.34 Million USD | 1.5% |
| 2023 Q3 | -5.42 Million USD | -35.06% |
| 2023 Q2 | -4.01 Million USD | 0.0% |
| 2022 FY | - NZD | -31.86% |
| 2022 Q2 | -6.59 Million USD | 0.0% |
| 2022 Q4 | -7.73 Million USD | 0.0% |
| 2021 Q2 | -4.67 Million USD | 0.0% |
| 2021 FY | - NZD | -0.6% |
| 2021 Q4 | -5.93 Million USD | 0.0% |
| 2020 Q2 | -5.7 Million USD | 0.0% |
| 2020 Q4 | -5.44 Million USD | 0.0% |
| 2020 FY | - NZD | 42.51% |
| 2019 FY | - USD | 9.22% |
| 2018 FY | - USD | 11.81% |
| 2017 FY | - USD | -94.82% |
| 2016 FY | - USD | -24.82% |
| 2015 FY | - NZD | -19.41% |
| 2014 FY | - NZD | -66.17% |
| 2013 FY | - NZD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -2676.956% |
| Arrayit Corporation | -3.07 Million USD | -949.425% |
| Atlantic International Corp. | -5.38 Million USD | -499.233% |
| Biocept, Inc. | -30.24 Million USD | -6.795% |
| Bioqual, Inc. | 3.03 Million USD | 1165.087% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -4164.202% |
| DermTech, Inc. | -97.89 Million USD | 67.009% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 101.108% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | -59.546% |
| iMD Companies, Inc. | -154.65 Thousand USD | -20782.07% |
| IDenta Corp. | 71.58 Thousand USD | 45214.336% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 941.699% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 83573.766% |
| InVitro International | 6680.00 USD | 483573.054% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -494.113% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -266061.2% |
| Medical Imaging Corp. | -896.74 Thousand USD | -3501.482% |
| NovelStem International Corp. | -3.78 Million USD | -753.083% |
| Optigenex Inc. | -1.18 Million USD | -2621.442% |
| PharmChem, Inc. | 1.05 Million USD | 3164.689% |
| Proteome Sciences plc | -1.13 Million USD | -2740.457% |
| Response Genetics, Inc | -19.66 Million USD | -64.223% |
| Rennova Health, Inc. | -234.81 Thousand USD | -13653.806% |
| RushNet, Inc. | -614.85 Thousand USD | -5152.646% |
| ScreenPro Security Inc. | -3.43 Million USD | -840.234% |
| Stella Diagnostics Inc. | -5.7 Million USD | -465.859% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -214.465% |
| Todos Medical Ltd. | -9.39 Million USD | -243.794% |